|
| Real Time news |
|
|
 |
|
|
| HospitalPharma.com
today |
13 May 2008
|
NICE backs Merck KGaA’s Erbitux in head/neck cancers
The National Institute for Health and Clinical Excellence has issued a Final Appraisal Determination recommending the use of Merck KGaA’s Erbitux (cetuximab) in combination with radiotherapy for the treatment of locally-advanced head and neck cancer in National Health Service patients in England and Wales who are contraindicated to all forms of platinum based chemoradiotherapy.
more HospitalPharma.com today stories |
View article as featured on pharmatimes.com
|
| Breaking Drug Discovery Articles |
| Click the 'more' link below to be taken to the latest journal article entries in the area of drug discovery, provided by http://www.leaddiscovery.co.uk. |
|
|
Latest
Features |
 |
 Anti-Obesity Treatments 2007-2012
09 May 08
“By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, research has found”. |
 |
What Is Crohn's Disease?
07 May 08
|
 |
What is obesity?
06 May 08
Obesity is the heavy accumulation of fat in your body to such a degree that it rapidly increases your risk of diseases that can damage your health and knock years off your life, such as heart disease and diabetes. |
|
|
|
| Latest
Poll |
| CPD - How important is it?
|
|
 |
|
